BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5171628)

  • 1. Studies on the interaction of long-acting thyroid stimulator (LATS) with soluble thyroid fractions.
    Amino N; Miyai K; Azukizawa M; Kumahara Y
    Acta Endocrinol (Copenh); 1971 Dec; 68(4):625-44. PubMed ID: 5171628
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nature of "LATS" immunoglobulin with prolonged thyreotropic action and localization of its antigen].
    Benhamou-Glynn N
    Ann Inst Pasteur (Paris); 1970 Apr; 118(4):539-46. PubMed ID: 5421296
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effects of thyrotrophin and long-acting thyroid stimulator on iodide trapping in isolated thyroid cells.
    Burke G; Kowalski K
    Acta Endocrinol (Copenh); 1971 Dec; 68(4):645-56. PubMed ID: 5171629
    [No Abstract]   [Full Text] [Related]  

  • 4. Heterogeneity of long acting thyroid stimulating (LATS)-activity, thyroglobulin antibodies and thyroid microsomal antibodies.
    Adlkofer F; Schleusener H; Uher L; Ananos A
    Acta Endocrinol (Copenh); 1973 Jul; 73(3):483-8. PubMed ID: 4740843
    [No Abstract]   [Full Text] [Related]  

  • 5. Inactivation of long-acting thyroid stimulator in vivo.
    Smith BR; Munro DS
    J Endocrinol; 1972 Jan; 52(1):189-96. PubMed ID: 5061150
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterisation of long-acting thyroid stimulator gamma-G binding protein.
    Smith BR
    Biochim Biophys Acta; 1971 Mar; 229(3):649-62. PubMed ID: 4929149
    [No Abstract]   [Full Text] [Related]  

  • 7. [Discrepancy between thyroid stimulation by LATS and inactivation by thyroid microsomes].
    Shishiba Y; Shimizu T; Yoshimura S; Shizume K
    Nihon Naibunpi Gakkai Zasshi; 1970 May; 46(2):122-6. PubMed ID: 5463390
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative studies on the reduction of the response to the long-acting thyroid stimulator by soluble fractions from human, ovine, bovine and porcine thyroids.
    Dirmikis S; Munro DS
    J Endocrinol; 1973 Dec; 59(3):579-92. PubMed ID: 4761687
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence that both long-acting thyroid stimulator and long-acting thyroid stimulator-protector stimulate the human thyroid gland.
    Holmes SD; Dirmikis SM; Martin TJ; Munro DS
    J Endocrinol; 1979 Feb; 80(2):215-21. PubMed ID: 220366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct evidence for human thyroidal stimulation by LATS-protector.
    Shishiba Y; Shimizu T; Yoshimura S; Shizume K
    J Clin Endocrinol Metab; 1973 Mar; 36(3):517-21. PubMed ID: 4739312
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of the long-acting thyroid stimulator (LATS) by soluble thyroid fractions.
    Beall G; Doniach D; Roitt I; el Kabir D
    J Lab Clin Med; 1969 Jun; 73(6):988-99. PubMed ID: 4977698
    [No Abstract]   [Full Text] [Related]  

  • 12. Failure of immunologic reaction of long acting thyroid stimulator (LATS) to thyroid components, and the demonstration of a plasma inhibitor LATS.
    Burke G
    J Lab Clin Med; 1967 May; 69(5):713-27. PubMed ID: 4960804
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inactivation of the thyroid-stimulating and exophthalmogenic effect of TSH, LATS, EPF, thyroid antibodies and serum protein fractions by iodine].
    Schemmel K; Streich D; Kreysing G; Leybold K; Weisbecker L
    Klin Wochenschr; 1969 Aug; 47(16):879-83. PubMed ID: 5393915
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the thyroid gland component inhibiting LATS.
    Schleusener H; Murthy PV; McKenzie JM
    Metabolism; 1971 Mar; 20(3):299-308. PubMed ID: 4993770
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of long-acting thyroid stimulator by thyroid particulate fractions.
    Beall GN; Solomon DH
    J Clin Invest; 1966 Apr; 45(4):552-61. PubMed ID: 5937026
    [No Abstract]   [Full Text] [Related]  

  • 16. On the competitive interaction of long-acting thyroid stimulator and thyrotropin in vivo.
    Burke G
    J Clin Endocrinol Metab; 1968 Feb; 28(2):286-93. PubMed ID: 5636155
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of the actions of thyroid-stimulating hormone and the long-acting thyroid stimulator in an in vitro assay.
    Brown J; Ensor J; Munro DS
    Proc R Soc Med; 1968 Jul; 61(7):652-4. PubMed ID: 5664277
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulating inhibitor of LATS: a bioassay artefact.
    Burke G
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1244-50. PubMed ID: 4740050
    [No Abstract]   [Full Text] [Related]  

  • 19. THYROTROPIN AND LONG-ACTING THYROID STIMULATOR ASSAYS IN THYROID DISEASE.
    PINCHERA A; PINCHERA MG; STANBURY JB
    J Clin Endocrinol Metab; 1965 Feb; 25():189-208. PubMed ID: 14264241
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of thyroid antigens by the experimental production of precipitating antibodies to human thyroid fractions and the identification of an antibody which competes with long-acting thyroid stimulator (LATS) for thyroid binding.
    von Westarp C; Knox AJ; Row VV; Volpé R
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):759-67. PubMed ID: 576759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.